10 Biggest Price Target Changes For Friday
- Wedbush boosted the price target for Starbucks Corporation (NASDAQ: SBUX) from $88 to $101. Starbucks shares rose 0.4% to $100.55 in pre-market trading.
- Needham boosted Docusign Inc (NASDAQ: DOCU) price target from $240 to $275. Docusign shares gained 5.2% to $243.05 in pre-market trading.
- Stephens & Co. raised the price target on NCR Corporation (NYSE: NCR) from $30 to $39. NCR shares rose 3.8% to close at $31.33 on Thursday.
- Barclays lifted the price target for Chemours Co (NYSE: CC) from $26 to $28. Chemours shares fell 0.4% to $25.58 in pre-market trading.
- KeyBanc boosted the price target on Cooper Companies Inc (NYSE: COO) from $349 to $367. Cooper Companies shares rose 0.1% to $338.00 in pre-market trading.
- HC Wainwright & Co. raised TRACON Pharmaceuticals Inc (NASDAQ: TCON) price target from $7 to $12. TRACON Pharmaceuticals shares fell 2.1% to close at $9.15 on Thursday.
- SVB Leerink raised BridgeBio Pharma Inc (NASDAQ: BBIO) price target from $39 to $44. BridgeBio Pharma shares rose 3.4% to close at $50.51 on Thursday.
- Chardan Capital boosted the price target for Mesoblast limited (NASDAQ: MESO) from $5.5 to $7.5. Mesoblast shares fell 6.3% to $14.75 in pre-market trading.
- Mizuho lifted SAGE Therapeutics Inc (NASDAQ: SAGE) price target from $77 to $81. SAGE Therapeutics shares rose 2.6% to $71.70 in pre-market trading.
- KeyBanc lifted price target for Phreesia Inc (NYSE: PHR) from $37 to $50. Phreesia shares rose 2.1% to close at $44.92 on Thursday.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Price Target ChangesPrice Target Small Cap Pre-Market Outlook Analyst Ratings
